Working hours24*7 AvailableCall us+91 9967979080
ENCORAFENIB CAPSULE

Encorafenib

Generic Name/API:Encorafenib
Packaging:75 mg capsules available in cartons containing two bottles of 90 capsules each and cartons containing two bottles of 60 capsules each.
Storage:Store at 20°C to 25°C (68°F to 77°F).
Dosage:For dosage information, please visit the General Information section.
Strength:Each capsule contains 75 mg encorafenib.
Indication:BRAFTOVI (encorafenib) is a targeted therapy designed for adults with melanoma, NSCLC, and colorectal cancer with a BRAF mutation that have spread or cannot be surgically removed. BRAFTOVI helps improve tumor response and duration of benefit. When paired with binimetinib or cetuximab-based regimens, it offers powerful, personalized treatment designed to enhance anti-tumor response and extend control. It is not suitable for cancers without the BRAF mutation.

BRAFTOVI (Encorafenib) is a prescription medication used to treat certain cancers that have spread (metastasized), cannot be removed with surgery, and have specific mutations in the BRAF gene. It is used in the following ways:

  1. Melanoma and Non-Small Cell Lung Cancer (NSCLC): In combination with MEKTOVI (binimetinib), BRAFTOVI is used to treat adults with melanoma or NSCLC that has a BRAF mutation.
  2. Colorectal Cancer (CRC): In combination with cetuximab and mFOLFOX6 (a chemotherapy regimen including fluorouracil, leucovorin, and oxaliplatin) to treat colorectal cancer.

The approval for this combination was based on tumor response and the duration of that response. Ongoing studies are evaluating the clinical benefit of this regimen.
Encorafenib may also be used in combination with cetuximab alone for adults with colorectal cancer who have previously received treatment.

Important Note:
Encorafenib should not be used in people whose melanoma, colorectal cancer, or NSCLC has wild-type BRAF (no mutation). Your healthcare provider will perform a test to confirm if Encorafenib or the combination with binimetinib is appropriate for your condition.

It is currently not known whether encorafenib or binimetinib is safe or effective in children.

Encorafenib is a BRAF kinase inhibitor targeting mutated BRAF – BRAF V600E, wild-type BRAF, and CRAF, inhibiting tumor growth via the suppression of RAF/MEK/ERK pathway. It also binds other kinases at clinically relevant levels. In combination with binimetinib or cetuximab, it showed enhanced anti-tumor effects and delayed resistance in BRAF-mutant models. Resistance in BRAF-mutant CRC due to EGFR activation can be overcome with EGFR-targeted combination therapy.

STRENGTH:

Each capsule contains 75 mg encorafenib. 

DOSAGE:  

Recommended Dosage for:

BRAF V600E or V600K Mutation-Positive Unresectable or Metastatic Melanoma: 450 mg (six 75 mg capsules) orally once daily in combination with binimetinib until disease progression or unacceptable toxicity. Recommended binimetinib prescribing information for dosage to be referred separately. 

Dose reductions: 

  • 1st dose reduction: 300 mg (four 75 mg capsules) orally once daily
  • 2nd dose reduction: 225 mg (three 75 mg capsules) orally once daily 
  • Subsequent Modification: Permanently discontinue if unable to tolerate encorafenib 225 mg (three 75 mg capsules) once daily

BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (CRC): 300 mg (four 75 mg capsules) orally once daily in combination with cetuximab until disease progression or unacceptable toxicity. Recommended cetuximab prescribing information for dosage to be referred separately. 

Dose reductions: 

  • 1st dose reduction: 225 mg (three 75 mg capsules) orally once daily 
  • 2nd dose reduction: 150mg (two 75 mg capsules) orally once daily
  • Subsequent Modification: Permanently discontinue if unable to tolerate encorafenib 150mg (two 75 mg capsules) once daily

Encorafenib may be taken with or without food. Do not take a missed dose of encorafenib within 12 hours of the next dose of the same. Do not take an additional dose if vomiting occurs post administration, but continue with the next scheduled dose.

  1. New Primary Malignancies: Cutaneous malignancies like cutaneous squamous cell carcinoma (including keratoacanthoma) and basal cell carcinoma;  and non-cutaneous malignancies have occurred with encorafenib treatment. Regular dermatologic exams are recommended. Manage skin lesions by excision; no dose change is required for cutaneous malignancies. Discontinue for RAS-mutant non-cutaneous cancers.
  2. Tumor Promotion in BRAF Wild-Type Tumors: Encorafenib may paradoxically activate MAPK signaling in BRAF wild-type cells. Confirm BRAF V600E/K mutation before initiating treatment.
  3. Hemorrhage: Hemorrhage (Grade ≥3 in ~3% of cases) reported with encorafenib + binimetinib or cetuximab. Common sites include GI tract and nasal passages. Withhold, reduce, or discontinue based on severity.
  4. Uveitis: Uveitis (4% incidence) may occur with encorafenib + binimetinib. Monitor for visual symptoms and perform ophthalmologic exams as needed. Withhold treatment if necessary.
  5. QTc Prolongation: QTc prolongation has been observed; 0.5% had QTcF >500 ms. Monitor high-risk patients. Correct electrolytes and modify dose for significant prolongation.
  6. Fetal Harm and Contraception: Encorafenib can harm a fetus and reduce hormonal contraceptive effectiveness. Use effective non-hormonal contraception during and for 2 weeks post-treatment.
  7. Monotherapy vs Combination Use: Single-agent encorafenib has higher risk of severe skin reactions (21%) vs combination (2%). Reduce encorafenib dose if binimetinib is interrupted or discontinued.

 

Process to Import Medicine

FAQ

  • What is encorafenib?
  • What is encorafenib used for?
  • What are the common side effects of encorafenib use?
  • Can encorafenib be used in specific populations i.e. for pregnant, breastfeeding , pediatric and geriatric use?
  • What is the cost of Encorafenib 75mg Capsules in India?
  • How to buy Encorafenib 75mg Capsules Online in India?
  • What are the key criteria for selecting a supplier?
What is encorafenib?

Encorafenib is a BRAF kinase inhibitor targeting mutated BRAF – BRAF V600E, wild-type BRAF, and CRAF, inhibiting tumor growth via the suppression of RAF/MEK/ERK pathway.

What is encorafenib used for?

Encorafenib is a therapy for adults with melanoma, NSCLC, and colorectal cancer with a BRAF mutation that have spread or cannot be surgically removed. When used in combination with binimetinib or cetuximab-based regimens, it enhances antitumor response. It is not suitable for cancers without the BRAF mutation.

What are the common side effects of encorafenib use?

New primary malignancies, hemorrhage, uveitis and QT prolongation are the common side effects of encorafenib treatment.

Can encorafenib be used in specific populations i.e. for pregnant, breastfeeding , pediatric and geriatric use?

Presence of encorafenib in breast milk and effects on infants are unknown; breastfeeding is not recommended during treatment and for 2 weeks after. Encorafenib may impair male fertility and reduce the effectiveness of hormonal contraceptives; non-hormonal contraception is advised. Pregnancy status should be confirmed before treatment, and effective contraception used during and for 2 weeks after therapy. In clinical trials, no differences in safety or effectiveness were seen in elderly patients compared to younger ones. Encorafenib is not approved for pediatric use. No dose adjustment is needed for mild to moderate renal or hepatic impairment, and use in severe impairment lacks dosing recommendations.

What is the cost of Encorafenib 75mg Capsules in India?

The cost of Encorafenib 75 mg may vary, as it is not approved in India and must be imported. Pricing depends on currency rates and import duties. For details, contact 247 QualityMeds.

How to buy Encorafenib 75mg Capsules Online in India?

To buy Braftovi (Encorafenib) 75 mg Capsules online in India at a genuine price, contact 247 QualityMeds. We assist you in importing this medication legally and at the best possible price.

What are the key criteria for selecting a supplier?

While selecting a supplier, we essentially ensure that the supplier holds a valid Good Distribution Practice (GDP) certificate and possesses a valid operating license. These credentials confirm that the suppliers adherence to International standards for the proper distribution of medicinal product

"I am very happy with experience of delivery medicine! From start to finish, everything was smooth, professional, and exceeded my expectations. The coordinator was incredibly responsive and friendly, and the product itself best in condition exactly as described. Delivery was fast, packaging was secure, and I felt truly valued as a customer. I’ll be coming back and recommending this to friends and family. Once again Thanks for delivering medicine with in 24 hours which help my wife to start treatment on time. "

- Mr. Sanjay More

"I’ve been using this medicine delivery service for a few months now, and I couldn’t be happier. The ordering process is simple and user-friendly, and the delivery is always prompt and reliable. I especially appreciate the timely updates, which help me stay on track with my prescriptions. The coordinator team is responsive and genuinely helpful, always ready to answer questions or resolve any issues. The packaging is secure, and the medicines always arrive in perfect condition. This service has made managing my health so much easier and stress-free. Highly recommended for anyone looking for convenience, reliability, and great customer care! "

- Mr. Nilesh Patankar

"I’m really impressed with the level of service. From placing the order to receiving the medicines, everything is smooth and hassle-free. The coordinator even called several times for updates my package. It’s rare to find such thoughtful service these days!"

- Mr. Mohit Vishwakarma

About us

We're a dedicated team of medicine access experts, doctors and pharmacists. We come from all over the world. And we've lost family and friends who could not get the medicine they needed because they lived in the wrong country.

Our mission is to get everyone the right treatment at the right time. Wherever you live. Because you should not suffer or die if a treatment that could help you exists somewhere.

Learn more ›

If you have any questions or need help, we're a phone call away. Our team is available from Monday to Friday between 9 a.m and 6 p.m CET

We usually respond to emails within 24 working hours

Worldwide Delivery

Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, Antigua & Barbuda, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia & Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, British Virgin Islands, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling) Islands, Colombia, Comoros, Congo - Brazzaville, Congo - Kinshasa, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czechia, Côte d'Ivoire, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guernsey, Guinea, Guinea-Bissau, Guyana, Haiti, Heard & McDonald Islands, Honduras, Hong Kong SAR China, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Isle of Man, Israel, Italy, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macao SAR China, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar (Burma), Namibia, Nauru, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, North Korea, North Macedonia, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Palestinian Territories, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn Islands, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Réunion, Saint Barthélemy, Samoa, San Marino, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Georgia & South Sandwich Islands, South Korea, Spain, Sri Lanka, St. Helena, St. Kitts & Nevis, St. Lucia, St. Martin, St. Pierre & Miquelon, St. Vincent & Grenadines, Sudan, Suriname, Svalbard & Jan Mayen, Sweden, Switzerland, Syria, São Tomé & Príncipe, Taiwan, Province of China, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tokelau, Tonga, Trinidad & Tobago, Tunisia, Turkey, Turkmenistan, Turks & Caicos Islands, Tuvalu, U.S. Outlying Islands, U.S. Virgin Islands, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Vatican City, Venezuela, Vietnam, Wallis & Futuna, Western Sahara, Yemen, Zambia, Zimbabwe, Åland Islands

Disclaimer

All trademarks, logos, brand names, and product names appearing on this website are the property of their respective owners. 247qualitymeds.com does not claim any ownership or affiliation with these trademarks or brands. They are used solely for informational and reference purposes to help users identify products and understand their intended use. The presence of any trademark or brand name on this website does not imply endorsement, sponsorship, or association with 247qualitymeds.com in any form.